An observational study in Down Syndrome, sponsored by Badr University. Recruiting at 2 sites in Egypt. Open to participants aged 1 Year to 6 Years. Per ClinicalTrials.gov, last updated 2026-01-26.
Sponsored by Badr University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Down Syndrome with a site in Egypt — 5 open to participants now, 7 under way, none of them phase 3. Down Syndrome · Egypt.
Among the 21 studies in Down Syndrome with a site in Egypt, this one is one of 6 that started in 2025, is one of 6 observational ones, and was the 18th registered.
439 studies on the registry are indexed under Down Syndrome; 99 are open to participants now.
Browse Down Syndrome studies →5 of the 21 studies in Down Syndrome with a site in Egypt are open now. Recruiting first, the newest first:
Raheel Sanad · Sites in Egypt
Ages 3–5 · Healthy volunteers
Ragaee Saeed Mahmoud · Sites in Egypt
Ages 10–16 · Healthy volunteers
Ain Shams University · Sites in Egypt
Ages 18+ · Healthy volunteers
Assiut University · Sites in Egypt
Ages 2–5
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 74 Down Syndrome studies recruiting now, 14 (19%) set no upper age limit and 57 (77%) stop at 75 or younger; 60 take children under 18; 19 take healthy volunteers.
This study: 1 Year to 6 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 6 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 158 across 145 observational studies indexed under Down Syndrome.
Median enrollment 40 across the 15 interventional studies, 63 across the 6 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 21 has an industry lead sponsor. The 10 most frequent:
Badr University is the lead sponsor of 64 studies on the registry; 18 are open to participants now.
Badr University has 1 study filed under Down Syndrome — fewer than ten, so there is no comparison to draw.
1 of the studies in Down Syndrome with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07260136Sohag UniversityCervical Spine Abnormalities in Down Syndrome | 2026-12-23 |
Add it to your calendar (.ics) → With an account.
Among the 21 studies in Down Syndrome with a site in Egypt, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Baseline serum IgG, IgA, IgM (nephelometry), total WBC count (automated analyzer), RR (manual count), and SaO2 (pulse oximetry) were measured. Pearson or Spearman correlations were used to assess relationships between immune and respiratory variables, and with age
descriptive, cross-sectional study analyzed baseline data from 40 children with DS and acute pneumonia enrolled prior to intervention in a larger trial. Baseline serum IgG, IgA, IgM (nephelometry), total WBC count (automated analyzer), RR (manual count), and SaO2 (pulse oximetry) were measured. Pearson or Spearman correlations were used to assess relationships between immune and respiratory variables, and with age.
Data collection occurred at the inpatient pediatric ward of King Abdulaziz University Hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Baseline serum IgG, IgA, IgM (nephelometry), total WBC count (automated analyzer), RR (manual count), and SaO2 (pulse oximetry) were measured. Pearson or Spearman correlations were used to assess relationships between immune and respiratory variables, and with age.
serum IgG, IgA, IgM
Immunoglobulins: Concentrations of IgG(mg/dl) IgA,(mg/dl) and IgM (mg/dl) were determined from serum using an automated nephelometer
Time frame: Upon enrollment and prior to any intervention baseline data were collected
Respiratory Rate
Respiratory rate (breaths/minute) was determined by direct observation and counting of chest wall movements over one full minute
Time frame: Upon enrollment and prior to any intervention baseline data were collected
Arterial Oxygen Saturation (SaO2)
Peripheral oxygen saturation (%) was measured non-invasively via pulse oximetry
Time frame: Upon enrollment and prior to any intervention baseline data were collected
White Blood Cell count
Total WBC count (thousands/mm³) was measured from a whole blood sample using an ADVIA 120 automated hematology analyzer
Time frame: Upon enrollment and prior to any intervention baseline data were collected
Plan to share: Undecided — The investigators have not yet determined whether individual participant data will be shared. Any future decision will depend on institutional policies, ethical considerations, and applicable data protection regulations."
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Jan 2026, 6 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Badr University